Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 78

1.

Mitochondrial therapeutics in Alzheimer's disease and Parkinson's disease.

Hoekstra JG, Montine KS, Zhang J, Montine TJ.

Alzheimers Res Ther. 2011 Jun 29;3(3):21. doi: 10.1186/alzrt83.

PMID:
21722346
[PubMed]
Free PMC Article
2.

Mitochondrial dynamics--fusion, fission, movement, and mitophagy--in neurodegenerative diseases.

Chen H, Chan DC.

Hum Mol Genet. 2009 Oct 15;18(R2):R169-76. doi: 10.1093/hmg/ddp326. Review.

PMID:
19808793
[PubMed - indexed for MEDLINE]
Free PMC Article
3.

Regulation of mitochondrial dynamics and neurodegenerative diseases.

Han XJ, Tomizawa K, Fujimura A, Ohmori I, Nishiki T, Matsushita M, Matsui H.

Acta Med Okayama. 2011 Feb;65(1):1-10. Review.

PMID:
21339790
[PubMed - indexed for MEDLINE]
Free Article
4.

Mitochondrial fusion/fission, transport and autophagy in Parkinson's disease: when mitochondria get nasty.

Arduíno DM, Esteves AR, Cardoso SM.

Parkinsons Dis. 2011 Feb 20;2011:767230. doi: 10.4061/2011/767230.

PMID:
21403911
[PubMed]
Free PMC Article
5.

Redox regulation of mitochondrial fission, protein misfolding, synaptic damage, and neuronal cell death: potential implications for Alzheimer's and Parkinson's diseases.

Nakamura T, Lipton SA.

Apoptosis. 2010 Nov;15(11):1354-63. doi: 10.1007/s10495-010-0476-x. Review.

PMID:
20177970
[PubMed - indexed for MEDLINE]
Free PMC Article
6.

The failure of mitochondria leads to neurodegeneration: Do mitochondria need a jump start?

Lee J, Boo JH, Ryu H.

Adv Drug Deliv Rev. 2009 Nov 30;61(14):1316-23. doi: 10.1016/j.addr.2009.07.016. Epub 2009 Aug 27. Review.

PMID:
19716395
[PubMed - indexed for MEDLINE]
Free PMC Article
7.

Mitochondrial dysfunction and oxidative damage in Alzheimer's and Parkinson's diseases and coenzyme Q10 as a potential treatment.

Beal MF.

J Bioenerg Biomembr. 2004 Aug;36(4):381-6. Review.

PMID:
15377876
[PubMed - indexed for MEDLINE]
8.

Mitochondrial dynamics and Parkinson's disease: focus on parkin.

Lim KL, Ng XH, Grace LG, Yao TP.

Antioxid Redox Signal. 2012 May 1;16(9):935-49. doi: 10.1089/ars.2011.4105. Epub 2011 Jul 22. Review.

PMID:
21668405
[PubMed - indexed for MEDLINE]
Free PMC Article
9.

Mitochondrial dysfunction in neurodegenerative diseases.

Johri A, Beal MF.

J Pharmacol Exp Ther. 2012 Sep;342(3):619-30. doi: 10.1124/jpet.112.192138. Epub 2012 Jun 13. Review.

PMID:
22700435
[PubMed - indexed for MEDLINE]
Free PMC Article
10.

Mitochondrial dynamics in cell death and neurodegeneration.

Cho DH, Nakamura T, Lipton SA.

Cell Mol Life Sci. 2010 Oct;67(20):3435-47. doi: 10.1007/s00018-010-0435-2. Epub 2010 Jun 25. Review.

PMID:
20577776
[PubMed - indexed for MEDLINE]
11.

Mitochondrial diseases of the brain.

Chaturvedi RK, Flint Beal M.

Free Radic Biol Med. 2013 Oct;63:1-29. doi: 10.1016/j.freeradbiomed.2013.03.018. Epub 2013 Apr 6. Review.

PMID:
23567191
[PubMed - indexed for MEDLINE]
12.

Insights on altered mitochondrial function and dynamics in the pathogenesis of neurodegeneration.

McInnes J.

Transl Neurodegener. 2013 May 27;2(1):12. doi: 10.1186/2047-9158-2-12.

PMID:
23711354
[PubMed]
Free PMC Article
13.

Pathway Analysis of ChIP-Seq-Based NRF1 Target Genes Suggests a Logical Hypothesis of their Involvement in the Pathogenesis of Neurodegenerative Diseases.

Satoh J, Kawana N, Yamamoto Y.

Gene Regul Syst Bio. 2013 Nov 4;7:139-52. doi: 10.4137/GRSB.S13204. eCollection 2013.

PMID:
24250222
[PubMed]
Free PMC Article
14.

Targeting mitochondrial dysfunction in neurodegenerative disease: Part I.

Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H.

Expert Opin Ther Targets. 2010 Apr;14(4):369-85. doi: 10.1517/14728221003652489. Review.

PMID:
20184395
[PubMed - indexed for MEDLINE]
15.

[Etiology and pathogenesis of Parkinson's disease: from mitochondrial dysfunctions to familial Parkinson's disease].

Hattori N.

Rinsho Shinkeigaku. 2004 Apr-May;44(4-5):241-62. Review. Japanese.

PMID:
15287506
[PubMed - indexed for MEDLINE]
16.

S-nitrosylation of Drp1 links excessive mitochondrial fission to neuronal injury in neurodegeneration.

Nakamura T, Cieplak P, Cho DH, Godzik A, Lipton SA.

Mitochondrion. 2010 Aug;10(5):573-8. doi: 10.1016/j.mito.2010.04.007. Epub 2010 May 4. Review.

PMID:
20447471
[PubMed - indexed for MEDLINE]
Free PMC Article
17.

Mitochondrial dynamics and mitophagy in the 6-hydroxydopamine preclinical model of Parkinson's disease.

Galindo MF, Solesio ME, Atienzar-Aroca S, Zamora MJ, Jordán Bueso J.

Parkinsons Dis. 2012;2012:131058. doi: 10.1155/2012/131058. Epub 2012 Aug 16.

PMID:
22966477
[PubMed]
Free PMC Article
18.

Inhibitors of mitochondrial fission as a therapeutic strategy for diseases with oxidative stress and mitochondrial dysfunction.

Reddy PH.

J Alzheimers Dis. 2014;40(2):245-56. doi: 10.3233/JAD-132060.

PMID:
24413616
[PubMed - in process]
Free PMC Article
19.

Targeting mitochondrial dysfunction in neurodegenerative disease: Part II.

Burchell VS, Gandhi S, Deas E, Wood NW, Abramov AY, Plun-Favreau H.

Expert Opin Ther Targets. 2010 May;14(5):497-511. doi: 10.1517/14728221003730434. Review.

PMID:
20334487
[PubMed - indexed for MEDLINE]
20.

Energetics in the pathogenesis of neurodegenerative diseases.

Beal MF.

Trends Neurosci. 2000 Jul;23(7):298-304. Review.

PMID:
10856939
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk